Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Head & Neck 1Gynecologic 1Genitourinary 1CNS 1

Conditions

Ovarian Neoplasms 4Testicular Neoplasms 3Prostatic Neoplasms 3Urinary Bladder Neoplasms 2Teratoma 2Small Cell Lung Carcinoma 2Sarcoma 2Ovarian Germ Cell Cancer 2Lung Neoplasms 2Kidney Neoplasms 2Drug-Related Side Effects and Adverse Reactions 2Central Nervous System Neoplasms 2Carcinoma, Ovarian Epithelial 2Carcinoma, Non-Small-Cell Lung 2Wilms Tumor 1Testicular Germ Cell Tumor 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Kaposi 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Retinoblastoma 1Radiation Injuries 1Osteosarcoma 1Neurotoxicity Syndromes 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroectodermal Tumors 1Neuroblastoma 1Neoplasms, Unknown Primary 1Melanoma 1Medulloblastoma 1

Interventions

Filgrastim 2Docetaxel 2etoposide phosphate 1entinostat 1Thalidomide 1Peripheral Blood Stem Cell Transplantation 1Ifosfamide 1Gemcitabine 1Etoposide 1Carboplatin 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
AIDS-related Kaposi sarcoma × Amifostine × Genitourinary × Clear all
NCT00003657 2017-01-20

High-dose ICE With Amifostine

Dana-Farber Cancer Institute

Phase 2 Completed
24 enrolled
CNSGenitourinaryGynecologicHead & NeckSarcomaThoracic

AIDS-related Kaposi sarcoma, Testicular Germ Cell Tumor, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasms, Unknown Primary, Ovarian Neoplasms, Sarcoma, Sarcoma, Kaposi, Osteosarcoma, Testicular Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡